Celldex Therapeutics
The biggest 3000 companies in the U.S. in the year of 2025.
Rating Overview
Rating Criteria
Rating Criteria Detail
Corporate Weaponization
Criteria:
Has canceled customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.
Risk Level:
MediumRationale:
Celldex integrates DEI into its executive compensation. From its 2026 Proxy Statement: “The Committee considers both quantitative and qualitative results and applies discretion when evaluating performance and determining total bonus payout potential. Based on its evaluation of our performance against our strategic goals, including the achievement of stretch goals, the Committee determined a payout factor of 100% of the target. In 2025, we accomplished the following significant milestones during the year:… Execute across Diversity and Inclusion (D&I) initiatives” (1). However, the company has not canceled customers, suppliers, or vendors based on political views or religious beliefs (2).
Criteria:
Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.
Risk Level:
N/ARationale:
Celldex does not publish charitable giving guidelines (1).
Criteria:
Employment policies fail to protect against viewpoint or other discrimination and/or are ideological in nature.
Risk Level:
HighRationale:
Celldex requires its employees to take DE&I training (1). The company appears to prioritize diversity over merit in its leadership composition. From its 2026 Proxy Statement: “Our Nominating and Corporate Governance Committee and our Board value diversity and, as such, also consider diversity of gender, race, sexual orientation, national origin, education, professional experience and differences in viewpoints and skills when selecting members of our Board, however we have no formal policy regarding diversity of our Board of Directors” (2). The company does not publish a nondiscrimination policy (3).
Corporate Governance and Public Policy
Criteria:
Uses corporate reputation to support causes, organizations, or policies hostile to freedom of expression.
Risk Level:
HighRationale:
Celldex supports DEI within its business practices. From its 2026 Annual Report: “Much of our success is rooted in the diversity of our teams and our commitment to inclusion. We value diversity at all levels and continue to focus on extending our diversity and inclusion initiatives across our entire workforce. We believe that our business benefits from the different perspectives that a diverse workforce brings” (1). The company supports ESG within its business practices. From its 2024 Proxy Statement: “We are committed to building a safe, environmentally sustainable, and ethical business that provides long-term value for all Celldex stakeholders. As part of this commitment, we support Environmental, Social and Governance (“ESG”) initiatives aligned to our mission, culture, and core values” (2).
Criteria:
Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.
Risk Level:
LowerRationale:
Celldex has not used corporate funds to advance ideological causes, organizations, or policies (1).